Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023
InfectologiaSobre o estudo
- Desenho
- Diretriz clínica
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- MMWR. Morbidity and mortality weekly report
- Publicado em
- 13 out 2023
- Citações
- 326
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023
Katherine E Fleming-Dutra, Jefferson M Jones, Lauren E Roper, Mila M Prill, Ismael R Ortega-Sanchez, Danielle L Moulia, Megan Wallace, Monica Godfrey, Karen R Broder, Naomi K Tepper et al.
Descritores MeSH
- Respiratory Tract Infections
- Respiratory Syncytial Virus, Human
- Respiratory Syncytial Virus Infections
- Respiratory Syncytial Virus Vaccines
- Communicable Diseases
- United States
- Vaccination
- Advisory Committees
- Female
- Humans